Metabolic Cofactor Supplementation in Alzheimer's Disease (AD) and Parkinson's Disease (PD) Patients Clinical Studies, Cognition, RecruitingANAD StaffAugust 4, 2021
NAD+ and Exercise in FA (ExRx in FA) Clinical Studies, Locomotion, RecruitingANAD StaffDecember 10, 2019
NIAGEN and Persistent Chemotherapy-Induced Peripheral Neuropathy Clinical Studies, Sensory, RecruitingANAD StaffOctober 2, 2019
Nicotinamide Riboside in Hospitalized Patients Clinical Studies, Vitality, RecruitingANAD StaffOctober 1, 2019
Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD Clinical Studies, Vitality, RecruitingANAD StaffAugust 1, 2019
Nicotinamide riboside for Treating Elevated systolic Blood Pressure and Arterial Stiffness in Middle-aged and Older Adults Clinical Studies, Vitality, RecruitingANAD StaffJanuary 30, 2019
Nicotinamide Riboside for Diabetic Neuropathy Clinical Studies, Sensory, RecruitingANAD StaffSeptember 26, 2018
NR in Chemo-induced Peripheral Neuropathy Clinical Studies, Sensory, RecruitingANAD StaffAugust 22, 2018
Trial of Nicotinamide Riboside and Co-enzyme Q10 in Chronic Kidney Disease Clinical Studies, Locomotion, RecruitingANAD StaffJuly 6, 2018
Effects of Nicotinamide Riboside on Metabolism and Vascular Function Clinical Studies, Vitality, RecruitingANAD StaffApril 18, 2018
NAD Therapy for Improving Memory and Brain Blood Flow in Older Adults With Mild Cognitive Impairment Clinical Studies, Cognition, RecruitingANAD StaffMarch 29, 2018
Nicotinamide Riboside and Mitochondrial Biogenesis Clinical Studies, Pharmacokinetic/Safety, RecruitingANAD StaffFebruary 14, 2018
The Effects of Nicotinamide Riboside Supplementation on NAD+/NADH Ratio and Bioenergetics Clinical Studies, Pharmacokinetic/Safety, RecruitingANAD StaffMay 12, 2017
Use of 31P MRS to Assess Brain NAD+ in Healthy Collegiate Athletes Clinical Studies, Pharmacokinetic/Safety, RecruitingANAD StaffMarch 29, 2016
